Explore all subjects

The Expertise Imperative and Compliance Technology
Access to a diverse array of specialized expert inputs drives superior decisions in every organizational context: within corporations, by investors and consultancies, and within nonprofits. When decision makers are confident of their decision inputs, they can respond more quickly and creatively to challenges and opportunities.Learn more about GLG's Compliance Framework


This page may include content provided by Council Members, your access to which is subject to the Terms of Use.
Find Out More

GLG News by Refractive Surgeons (US)

Sanjay Rao, MD, Medical Director
Sanjay Rao, MD, Medical Director
Lakeside Eye Clinic
March 9, 2007
Corneal inlays: Another entrant into the presbyopia treatment wars
Analysis of: Corneal inlay is versatile approach for presbyopia (www.ophthalmologytimes.com)
The early results of a new corneal inlay (PresbyLens, ReVision Optics) are presented.  A corneal inlay is placed underneath a LASIK corneal flap in the non-dominant eye to correct presbyopia.  This version of a corneal inlay is 1.5mm in diameter.  The outcomes of 15 patients showed good...
Sanjay Rao, MD, Medical Director
Sanjay Rao, MD, Medical Director
Lakeside Eye Clinic
March 7, 2007
Approval of Aspheric Restor lens: Another winner for Alcon?
Analysis of: Alcon's AcrySof(R) ReSTOR(R) Apodized Diffractive Aspheric Intraocular Lens Approved by FDA (biz.yahoo.com)
The recent approval of the aspheric version of the Restor multifocal intraocular lens is positive as most surgeons already understand the value of aspheric optics.  As shown with monofocal aspheric lenses, such as the Alcon IQ, Advanced Medical Optics' Tecnis, and Bausch and Lomb's Sofport, aspheric...
Sanjay Rao, MD, Medical Director
Sanjay Rao, MD, Medical Director
Lakeside Eye Clinic
March 7, 2007
Concerns about billing for multifocal IOLs may limit growth
Analysis of: Presbyopia-correcting IOLs present opportunity, but legal caution needed (www.osnsupersite.com)
The article describes some of the legal concerns in billing for presbyopia-correcting IOLs.  The ruling by the CMS (Centers for Medicaid and Medicare Services) in 2005 that essentially allowed surgeons to charge patients an additional out-of-pocket cost related to the implantation of these lenses...
Sanjay Rao, MD, Medical Director
Sanjay Rao, MD, Medical Director
Lakeside Eye Clinic
March 7, 2007
Xibrom: A potential blockbuster for post-operative eye pain?
Analysis of: ISTA Pharmaceuticals Announces Positive Preliminary Xibrom Once-daily Formulation Clinical Results From U.S. Phase III Trials (pharmalive.com)
The Phase III Trials of Xibrom showed excellent efficacy in the treatment of post cataract surgery pain and inflammation.  The trial involved 500 cataract patients and is important in that it demonstrates that a once-a-day formulation is effacacious in treating patients post-operatively. ...
March 5, 2007
The Value of Monitering Intraocular Pressure
By a GLG Expert Contributor
Analysis of: Cleveland Clinic Awarded Four New Patents for New Medical Devices (www.emaxhealth.com)
Glaucoma is an elusive diagnostic dilemma.  The aim of treatment is to lower the intraocular pressure below 18 mm of mercury.However in the practice of ophthalmology a single reading on the quarterly exam fails to demonstrate the fluctuations of pressure thatmay cause optic nerve damage in the...
Mark Packer, MD, Clinical Associate Professor of Ophthalmology
Mark Packer, MD, Clinical Associate Professor of Ophthalmology
OREGON HEALTH & SCIENCE UNIVERSITY - CC
February 26, 2007
Another Reason Adoption of Presbyopia Correcting IOLs is Slower than Expected
Analysis of: Presbyopia-correcting IOLs present opportunity, but legal caution needed (www.osnsupersite.com)
The Center for Medicare and Medicaid Services (CMS) has ruled that beneficiaries may pay out of pocket for additional non-covered services related to presbyopia and astigmatism correcting intraocular lenses (IOLs) that are provided by surgeons and facilities (such as Ambulatory Surgery Centers and Hospital...
February 23, 2007
Better Safe than Sorry- LASIK requires careful pre operative examinations
By a GLG Expert Contributor
Analysis of: Woman sues eye doctor for botched surgery (www.wvrecord.com)
This lay article proves again that lawyers are actively pursuing litigation in this profitable field.  Given that over 1 million people per year have this surgery, and physicians are under constant pressure to increase patient volumes, it is a potentially dangerous combination. ...
Barry Schechter, MD, Director of Corneal and External Diseases
Barry Schechter, MD, Director of Corneal and External Diseases
Florida Eye Microsurgical Institute, Inc.
February 14, 2007
ISTA takes the lead in topical NSAID therapy
Analysis of: ISTA Pharmaceuticals Announces Positive Preliminary Xibrom Once-daily Formulation Clinical Results From U.S. Phase III Trials (pharmalive.com)
There has been a sea change in the treatment of postoperative cataract patients. The addition of a nonsteroidal has significantly reduced postoperative complications such as edema, discomfort and inflammation.Compliance with all medications is always an issue, and the use of a once daily medication...
Sanjay Rao, MD, Medical Director
Sanjay Rao, MD, Medical Director
Lakeside Eye Clinic
January 18, 2007
Scleral expansion: A legitimate contender in the presbyobia arena?
Analysis of: Scleral spacing procedures investigated for presbyopia (www.ophthalmologytimes.com)
This article describes the Phase II trial results of the PreView Scleral Implants (ReFocus Group Inc.) for the treatment of presbyopia.  Presbyopia is the natural age related loss of accommodation, or near focusing ability that leads to people wearing reading glasses. Scleral implants alter the...
Sanjay Rao, MD, Medical Director
Sanjay Rao, MD, Medical Director
Lakeside Eye Clinic
January 10, 2007
AMO's Acquisition of Intralase: A clinician's perspective
Analysis of: AMO's IntraLase Acquisition Applauded By Analysts (www.forbes.com)
AMO's acquisition of Intralase for $808 million has been seen by most financial industry analysts as positive.  Most financial analysts point to the improved diversification and strengthening of AMO's refractive portfolio which includes intraocular lenses, phacoemulsification equipment, VISX excimer...

Previous Page : 1 2 3 4 5 6 7 8 9 Next61 to 70 of 83

Analytics


Generated at 2009-01-09T13:00:20.343